The Most Trusted Name in Securities Class Action Law Firms

Over $400 million recovered for investors in the last 2 years

AXT, Inc.

On April 4, 2024, J Capital Research released a report about AXT, Inc. (the “Report”). The Report stated that, in order to capture new financing,

Read More

Zoetis Inc.

On April 12, 2024, before the market opened, The Wall Street Journal released an article entitled “What Killed Their Pets? Owners Blame Meds, but Vets

Read More

Sharecare, Inc.

On March 29, 2024, Sharecare filed with the SEC its annual report on Form 10-K for the 2023 fiscal year. In this annual report, Sharecare

Read More

QuidelOrtho Corporation

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy

Read More

Morgan Stanley

On April 11, 2024, during market hours, The Wall Street Journal published an article entitled “Morgan Stanley’s Wealth Arm Probed by Multiple Federal Regulators.” The

Read More

Globe Life Inc.

On April 11, 2024, Fuzzy Panda Research published a report entitled, “Globe Life (GL): Executives Disregarded Wide-Ranging “Insurance Fraud” While They Received Millions in Undisclosed

Read More

Ocugen, Inc.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Ocugen’s financial statements from May 8,

Read More

Sonder Holdings Inc.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Sonder failed to disclose all issues

Read More

AXT, Inc.

On April 4, 2024, J Capital Research released a report about AXT, Inc. (the “Report”). The Report stated that, in order to capture new financing,

Read More

Zoetis Inc.

On April 12, 2024, before the market opened, The Wall Street Journal released an article entitled “What Killed Their Pets? Owners Blame Meds, but Vets

Read More

Sharecare, Inc.

On March 29, 2024, Sharecare filed with the SEC its annual report on Form 10-K for the 2023 fiscal year. In this annual report, Sharecare

Read More

QuidelOrtho Corporation

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy

Read More

Morgan Stanley

On April 11, 2024, during market hours, The Wall Street Journal published an article entitled “Morgan Stanley’s Wealth Arm Probed by Multiple Federal Regulators.” The

Read More

Globe Life Inc.

On April 11, 2024, Fuzzy Panda Research published a report entitled, “Globe Life (GL): Executives Disregarded Wide-Ranging “Insurance Fraud” While They Received Millions in Undisclosed

Read More

Ocugen, Inc.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Ocugen’s financial statements from May 8,

Read More

Sonder Holdings Inc.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Sonder failed to disclose all issues

Read More

Autodesk, Inc.

On April 1, 2024, after the market closed, Autodesk filed with the SEC a late filing notice on Form NT 10-K. In the late filing

Read More

Checkpoint Therapeutics, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Checkpoint had overstated its oversight of, and/or its establishment of

Read More

HireRight Holdings Corporation

According to the lawsuit, the Offering Documents made false and/or misleading statements and/or failed to disclose that: HireRight was exposed to customers with significant employment

Read More

CI&T Inc

On March 7, 2024, before the market opened, CI&T issued a press release entitled “Restatement of Previously Issued Financial Statements.” It stated, in pertinent part

Read More

Our Mission

The Rosen Law Firm, P.A. is dedicated to recovering damages for shareholders victimized by corporate fraud and other misconduct. Our attorneys have a wealth of knowledge and experience handling complex financial litigation and winning significant victories and settlements for our clients. By focusing exclusively on securities class actions and derivative litigation, we have risen to the forefront of plaintiffs’ firms and have recovered damages totaling hundreds of millions of dollars for our clients. Our mission is to protect shareholders rights.

In the News

FAQ

Class actions are lawsuits where one or more investors serve as the representative plaintiffs on behalf of a large group of investors that each purchased the same securities and suffered losses as a result of the same false statements or misconduct.  Class actions allow a court to decide the claims of many investors in a single lawsuit. This promotes efficiency, economy, and extends justice to investors whose claims are not large enough to merit an individual lawsuit.

This is the time period during which investors purchased securities in the company that is the subject of the class action.  Typically, the false statements or fraud begin on the first day of the class period and the full truth about the false statements or fraud is revealed on the last day of the class period.

A lead plaintiff is an investor that wishes to serve as a representative plaintiff in the class action on behalf of all the other investors that purchased securities during the Class Period.

The Lead Plaintiff’s role is to oversee the litigation with the assistance and advice of the class’s attorneys. Both the Lead Plaintiff and the class’s attorneys must direct the litigation for the benefit of the class foremost. Ultimately, it is the job of the Lead Plaintiff to decide what is a fair settlement amount for the Class and to approve any settlement offer.

Lead Counsel are the Class’s attorneys.  The Lead Plaintiff selects the Lead Counsel.  Lead Counsel should have extensive experience prosecuting securities class actions if they are to effectively represent investors in a securities class action. 

If the amount of your losses in the investment are significant to you, being a lead plaintiff allows you to be involved in the case and oversee important decisions in the litigation, particularly the amount of any settlement for investors.

Class action lawsuits often are filed when it would be impractical or prohibitively expensive for each person who was harmed to file an individual lawsuit, and they enable small shareholders or consumers to seek recovery from large corporations possessing much greater legal and financial resources. Generally, securities class actions are filed in the Federal District Courts and allege that the defendant(s) violated the Securities Act of 1933 and/or the anti-fraud provisions of the Securities Exchange Act of 1934. The typical class action takes at least 2-3 years to litigate, although the actual time it takes to resolve a case varies, depending on the complexity of the case, the issues involved, and other factors.

You can complete the online certification form on our website or at your request, we will email you a form to complete and you can send it back to us.

You do not pay any legal fees, costs or expenses. The Court will award the Lead Counsel any legal fees, costs or expenses from the money they recover for the class. If Lead Counsel doesn’t recover any money for the class, Lead Counsel doesn’t get paid any legal fees, costs or expenses.

Our Offices

New York

275 Madison Avenue,

40th Floor
New York, NY 10016
T: 212.686.1060
F: 212.202.3827

Los Angeles

355 South Grand Avenue, Suite 2450
Los Angeles, CA 90071
T: 213.785.2610
F: 213.226.4684

Philadelphia Metro

101 Greenwood Avenue,

Suite 440
Jenkintown, PA 19046
T: 215.600.2817

F: 212.202.3827

New Jersey

One Gateway Center,

Suite 2600
Newark, NJ 07102
T: 973.313.1887
F: 973.833.0399

Get a Free Consultation

Email us at [email protected] 

The Rosen Law Firm is dedicated exclusively to recovering investment losses for investors in companies that have misrepresented material aspects of their business or whose officers and directors have breached their fiduciary duties to shareholders.

Scroll to Top